Hengrui Pharma repurchases 150,000 A-shares for ESOP at RMB 46.89 average

Bulletin Express

Jun 11

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, H-share: 01276; A-share: 600276) disclosed a Next Day Disclosure Return on 11 June 2026, detailing an on-market share repurchase carried out the same day on the Shanghai Stock Exchange.

The company bought back 150,000 A-shares earmarked for its Employee Stock Ownership Schemes. Transaction prices ranged from RMB 46.85 to RMB 46.91 per share, with a volume-weighted average price of RMB 46.89. Total consideration amounted to RMB 7.03 million.

Following the repurchase, the number of issued shares (excluding treasury shares) fell from 6.37 billion to 6.37 billion, representing a 0.0024% reduction. Treasury shares increased to 8.19 million, while the total issued share count, including treasury shares, remained unchanged at 6.38 billion. No shares were repurchased for cancellation.

The board confirmed that the transaction was duly authorised and executed in compliance with all applicable listing rules and domestic regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1117137157"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117137157\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117137157?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 16:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117137157","market":"us","top_or_hot":-1,"title":"Hengrui Pharma repurchases 150,000 A-shares for ESOP at RMB 46.89 average","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, H-share: 01276; A-share: 600276) disclosed a Next Day Disclosure Return on 11 June 2026, detailing an on-market share repurchase carried out the same day on the Shanghai Stock Exchange.</p>\n<p>The company bought back 150,000 A-shares earmarked for its Employee Stock Ownership Schemes. Transaction prices ranged from RMB 46.85 to RMB 46.91 per share, with a volume-weighted average price of RMB 46.89. Total consideration amounted to RMB 7.03 million.</p>\n<p>Following the repurchase, the number of issued shares (excluding treasury shares) fell from 6.37 billion to 6.37 billion, representing a 0.0024% reduction. Treasury shares increased to 8.19 million, while the total issued share count, including treasury shares, remained unchanged at 6.38 billion. No shares were repurchased for cancellation.</p>\n<p>The board confirmed that the transaction was duly authorised and executed in compliance with all applicable listing rules and domestic regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma repurchases 150,000 A-shares for ESOP at RMB 46.89 average</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma repurchases 150,000 A-shares for ESOP at RMB 46.89 average\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 16:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, H-share: 01276; A-share: 600276) disclosed a Next Day Disclosure Return on 11 June 2026, detailing an on-market share repurchase carried out the same day on the Shanghai Stock Exchange.</p>\n<p>The company bought back 150,000 A-shares earmarked for its Employee Stock Ownership Schemes. Transaction prices ranged from RMB 46.85 to RMB 46.91 per share, with a volume-weighted average price of RMB 46.89. Total consideration amounted to RMB 7.03 million.</p>\n<p>Following the repurchase, the number of issued shares (excluding treasury shares) fell from 6.37 billion to 6.37 billion, representing a 0.0024% reduction. Treasury shares increased to 8.19 million, while the total issued share count, including treasury shares, remained unchanged at 6.38 billion. No shares were repurchased for cancellation.</p>\n<p>The board confirmed that the transaction was duly authorised and executed in compliance with all applicable listing rules and domestic regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1117137157","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117137157","pubTimestamp":1781167252,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, H-share: 01276; A-share: 600276) disclosed a Next Day Disclosure Return on 11 June 2026, detailing an on-market share repurchase carried out...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药回购15万股A股用于ESOP均价46.89元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, H-share: 01276; A-share: 600276) disclosed a Next Day Disclosure Return on 11 June 2026, detailing an on-market share repurchase carried out the same day on the Shanghai Stock Exchange.\nThe company bought back 150,000 A-shares earmarked for its Employee Stock Ownership Schemes. Transaction prices ranged from RMB 46.85 to RMB 46.91 per share, with a volume-weighted average price of RMB 46.89. Total consideration amounted to RMB 7.03 million.\nFollowing the repurchase, the number of issued shares (excluding treasury shares) fell from 6.37 billion to 6.37 billion, representing a 0.0024% reduction. Treasury shares increased to 8.19 million, while the total issued share count, including treasury shares, remained unchanged at 6.38 billion. No shares were repurchased for cancellation.\nThe board confirmed that the transaction was duly authorised and executed in compliance with all applicable listing rules and domestic regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}